Simplex Trading
ELDN icon

Simplex Trading’s Eledon Pharmaceuticals ELDN Stock Holding History

Simplex Trading’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1K Sell
8,800
-10,000
-53% -$23.6K ﹤0.01% 6492
2025
Q4 		$28.4K Buy
18,800
+12,600
+203% +$29.9K ﹤0.01% 6154
2025
Q3 		$16K Buy
6,200
+4,800
+343% +$14K ﹤0.01% 7525
2025
Q2 		$3K Buy
+1,400
New +$4.2K ﹤0.01% 7954
2024
Q4 		– Sell
-1,200
Closed -$2K – 8764
2024
Q3 		$2K Sell
1,200
-1,100
-48% -$2.95K ﹤0.01% 7983
2024
Q2 		$6K Buy
2,300
+400
+21% +$955 ﹤0.01% 7746
2024
Q1 		$3K Buy
+1,900
New +$3.39K ﹤0.01% 8243
2023
Q1 		– Sell
-2,900
Closed -$6K – 9271
2022
Q4 		$6K Hold
2,900
– – ﹤0.01% 7921
2022
Q3 		$8K Sell
2,900
-700
-19% -$2.23K ﹤0.01% 8394
2022
Q2 		$8K Buy
+3,600
New +$11K ﹤0.01% 8458

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Simplex Trading's ELDN Position: Q4 2025 in Review

Simplex Trading sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 15,997 shares — an estimated $38K sold.

Simplex Trading first reported a position in ELDN in Q2 2021 and held it in 13 quarters. The position peaked at $43K in Q4 2024. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • Simplex Trading reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 15,997 Eledon Pharmaceuticals shares in Q4 2025, an estimated $38K.
  • Simplex Trading first reported a position in Eledon Pharmaceuticals in Q2 2021 and held it in 13 quarters.
  • Simplex Trading's Eledon Pharmaceuticals position peaked at $43K in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.